| 2026-04-29T06:51:33.117170+00:00 |
audit_add_remaining_culturebotht
|
CREATED_AS_UNMAPPED |
UNMAPPED
|
Imported from CultureBotHT (compounds_to_cas.csv (no CAS-RN)). No CAS-RN or CHEBI mapping available; curator review needed. |
| 2026-05-11T08:12:15Z |
mediaingredientmech-agentic-curation
LLM
|
REVIEWED_COBAMIDE_VARIANT |
UNMAPPED
|
Classified as a single cobamide-family ingredient and left unmapped because no exact local ontology identity for the benzimidazolyl lower-ligand variant was verified. |
| 2026-06-17T00:00:00+00:00 |
deep-research-ingredient-edison
LLM
|
RESEARCHED_IDENTITY |
UNMAPPED
|
Edison/PaperQA3 deep research: underspecified — "benzimidazolyl cobamide" can denote multiple distinct cobamides (different lower ligands) and forms (CN-/Ado-); no stable CHEBI/CAS identifier. Kept UNMAPPED. |
| 2026-08-06T00:00:00+00:00 |
edison_literature_identity
LLM
|
ANNOTATED |
|
Edison LITERATURE (PaperQA3) identity research; report at research/ingredients/Benzimidazolyl_Cobamide-edison-literature.md (local artifact — research/ is gitignored, so the findings are quoted here rather than linked). Report verdict: **Recommended interpretation:** a cobamide bearing **unsubstituted benzimidazole as its lower-base moiety**, conventionally abbreviated **[Bza]Cba**, but with the cobalt upper ligand left unspecified. Modern nomenclature explicitly lists “[Bza]Cba” as benzimidazolylcobamide and distinguishes it from substituted benzimidazolyl cobamides such as [5-MeBza]Cba. Thus, the label is chemically more speci No ontology CURIE was proposed. Recorded as provenance only — no grounding applied from this run. Edison's recommendations are deliberately conservative, and a plausible identifier promoted by a mechanism that never decided anything is what #203 and #263 exist to undo. Any CURIE above is a curator's to accept or reject. |